Segmental Review
Hospitals/Healthcare Facilities
HMG is the leading private sector provider of integrated medical care in Saudi Arabia and the GCC. The Group owns and operates seven hospitals in Saudi Arabia and Dubai, a network of 14 pharmacies across the region, and offers innovative services through Cloud Solutions, Public-Private Partnerships, Laboratory Services and Home Healthcare.
Covid-19 aside, the regional healthcare landscape continues to change and grow, providing HMG the opportunity to adapt and expand to become a uniquely integrated healthcare provider across the continuum of care.
13,000+
Number of staff
60+
Number of sub specialities
1,370+
Number of clinics
3.2m+
Number of patients
1,900+
Number of beds
2,750
Number of physicians
78.5%
Revenue contribution
Accreditations
Radiology Accreditation
Health Facilities (CBAHI)
European Society of Nuclear Medicine
and Molecular Imaging (EANM)
Information Systems (HIMSS)
Expanding our Footprint
HMG continues to pursue an aggressive expansion plan. Despite market headwinds faced during the year, the Group remained committed and on track to deliver strategic projects in the coming years, announcing two new projects during the year, including the Maternity & Pediatric Hospital (New Takhassusi Expansion), and a new business segment for the Group with the introduction of the Medical Center at the Diplomatic Quarter.
North Riyadh
100%
ownership
2023
Expected completion date
SAR 669.7 mn
Land
SAR 2.2 bn
Construction
500
beds
300
clinics
South West Jeddah
50%
ownership
2023
Expected completion date
SAR 91 mn
Land
SAR 1.5 bn
Construction
330
beds
245
clinics
North Jeddah
100%
ownership
2024
Expected completion date
SAR 243.5 mn
Land
SAR 1.5 bn
Construction
350
beds
270
clinics
Maternity & Pediatric Hospital
(New Takhassusi Expansion)
100%
ownership
2024
Expected completion date
SAR 80.8 mn
Land
SAR 391 mn
Construction
145
beds
100
clinics
Medical Center at the
Diplomatic Quarter
Leased
agreement
2020
Completion
10 years
Land
17
clinics’ construction
Pharmacy
HMG’s Pharmacy segment delivered another year of strong growth, underpinned by a dynamic response to the pandemic. With 14 pharmacies and a team of 400+ employees, HMG’s Pharmacies plays a key role in the Group’s portfolio. In 2020, the Pharmacy segment increased its e-pharmacy service capacity, a service which was rolled out in 2019 and proved vital in maintaining the resilience of the business unit. During the year, the Pharmacy segment contributed 17.1% to total revenue.
HMG’s Pharmacies is the leading pharmacy in terms of product availability with more than 14,000 products on offer. In addition to pharmaceutical products, the branches also offer diet foods, beauty and healthcare appliances, cosmetics, personal care products, and baby care products.
17.1%
Contribution to
revenue
23,000+
e-pharmacy
transactions
37,500+
patients served
400+
Pharmacy
employees
4.31 out of 5
E-pharmacy patient
satisfaction rate
5,500+
subscribers in loyalty
program “Lakum”
14
pharmacies
HMG Solutions
HMG is strategically placed to deliver best in-class care through disruptive innovation and cutting-edge technology. As part of its strategic pillars, the Group has expanded its capabilities, expertise, and knowledge across a range of support and complementary fields to its core business.
HMG Solutions has a growing portfolio of specialized companies that are focused on hospital management, innovative technological solutions, participation in PPP programs, home healthcare and laboratory services. These companies and services align with the Group’s strategic pillars to broaden services, expand reach and drive healthcare innovation by investing in high-growth medical sectors to serve the needs of its hospitals and pharmacies, as well as the public and other private sector healthcare organizations across the Kingdom.
Cloud Solutions
HMG’s technological arm, Cloud Solutions maintained its momentum as the country’s leading healthcare technology provider in 2020. The Cloud Solutions team now employs more than 500 staff and has a state-of-the-art center specialized in health systems development and programing in Jordan and Sri Lanka, in addition to their GCC branches.
Public-Private Partnership (PPP)
In 2020, critical care units in the MoH operated hospitals were affected by the Covid-19 pandemic due to increasing need for critical care beds all over the country. ICU units operated by HMG were nominated by the MoH as Covid-19 referral centers (these included East Jeddah Hospital, Qatif Central Hospital, Buraidah Central Hospital). HMG’s track record resulted in the MoH appointing the Group to run 50 additional beds in Madinah - a project that required rapid deployment of ICU staff and equipment. The successful response provided additional care for patients and was included in a scientific journal as a case study of successful delivery of additional ICU capacity.
Home Healthcare
The Home Healthcare Company (HHC) service was significantly expanded during the year to meet increasing demands, resulting from movement restrictions across the country. Home Healthcare brings best in-class care to patients in the comfort of their homes. The need for in-home and remote services increased in 2020. HHC delivered care from a multi-disciplinary team of highly qualified physicians, and specialists, to more than 3,000 patients in the country. As the country continues to tackle the Covid-19 pandemic, demand for the Home Healthcare services is expected to grow, as teleconsultations and remote care becomes the new normal.
Medical Diagnostic Laboratory Services
The Covid-19 pandemic has been the largest defining event of 2020. MDLAB’s focus on swab testing and receiving swab samples from HMG’s Riyadh branches as well as from non-HMG laboratories placed significant stress on capacity and resources given a significant surge in testing required. The MDLAB team was resilient in its response, maintaining the quality of service and expanding capacity rapidly. MDLAB with its 80+ staff conducted more than six million laboratory tests in 2020.